We are live on ! Find out more
BBL

Beck Bode LLC Portfolio holdings

AUM $660M Turnover 45.93%
1-Year Est. Return 36.73%
This Fund
S&P 500
This Quarter Est. Return
-0.17%
1 Year Est. Return
+36.73%
3 Year Est. Return
+155.13%
5 Year Est. Return
+202.18%
10 Year Est. Return
–
AUM
$359M
AUM Growth
-$3.71M
Cap. Flow
-$286K
Cap. Flow %
-0.08%
Top 10 Hldgs %
37.43%
Holding
343
New
16
Increased
39
Reduced
25
Closed
256
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
OGE icon
OGE Energy
OGE
+$11.9M
2
VST icon
Vistra
VST
+$11.4M
3
HE icon
Hawaiian Electric Industries
HE
+$11.2M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$10.5M
5
MRVI icon
Maravai LifeSciences
MRVI
+$7.81M

Top Sells

Rank Stock Value
1
ACH icon
Accendra Health
ACH
+$13.3M
2
NGG icon
National Grid
NGG
+$12.9M
3
WTRG icon
Essential Utilities
WTRG
+$11.6M
4
POR icon
Portland General Electric
POR
+$10.9M
5
AMZN icon
Amazon
AMZN
+$9.5M

Sector Composition

Rank Sector Weight
1 Utilities 31.48%
2 Technology 26.03%
3 Healthcare 24.02%
4 Communication Services 7.26%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
26
Apple
AAPL
$5.02T
$6.55M 1.83%
46,266
-968
-2% -$143K
2021 Q1
2 quarters
NBIX icon
27
Neurocrine Biosciences
NBIX
$13.9B
$6.02M 1.68%
+62,740
New +$5.93M
2021 Q3
0 quarters
ISRG icon
28
Intuitive Surgical
ISRG
$151B
$5.7M 1.59%
17,196
+1,155
+7% +$388K
2021 Q2
1 quarter
UTHR icon
29
United Therapeutics
UTHR
$23.6B
$5.22M 1.46%
+28,286
New +$5.57M
2021 Q3
0 quarters
LUNG icon
30
Pulmonx
LUNG
$77.7M
$4.62M 1.29%
128,339
+11,897
+10% +$468K
2021 Q2
1 quarter
ABBV icon
31
AbbVie
ABBV
$506B
$4.38M 1.22%
40,610
-191
-0.5% -$21.8K
2021 Q2
1 quarter
FDX icon
32
FedEx
FDX
$69.3B
$4.27M 1.19%
19,481
+739
+4% +$201K
2021 Q1
2 quarters
ONEM
33
DELISTED
1Life Healthcare
ONEM
$3.82M 1.07%
+188,589
New +$4.85M
2021 Q3
0 quarters
DRVN icon
34
Driven Brands
DRVN
$1.99B
$3.42M 0.95%
+118,414
New +$3.51M
2021 Q3
0 quarters
AXSM icon
35
Axsome Therapeutics
AXSM
$8.61B
$3.37M 0.94%
+102,127
New +$3.98M
2021 Q3
0 quarters
FTV icon
36
Fortive
FTV
$17.4B
$3.33M 0.93%
+62,657
New +$3.43M
2021 Q3
0 quarters
DDOG icon
37
Datadog
DDOG
$94.6B
$3.06M 0.85%
21,661
-12,500
-37% -$1.58M
2021 Q1
2 quarters
FTNT icon
38
Fortinet
FTNT
$132B
$2.6M 0.73%
44,585
-525
-1% -$30.4K
2021 Q1
2 quarters
LOW icon
39
Lowe's Companies
LOW
$110B
$2.4M 0.67%
11,839
+558
+5% +$111K
2021 Q1
2 quarters
NARI icon
40
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.26M 0.63%
+27,853
New +$2.34M
2021 Q3
0 quarters
ROK icon
41
Rockwell Automation
ROK
$46.8B
$1.82M 0.51%
6,206
+366
+6% +$112K
2021 Q2
1 quarter
SPB icon
42
Spectrum Brands
SPB
$1.81B
$1.82M 0.51%
19,013
+966
+5% +$82.1K
2021 Q1
2 quarters
XRAY icon
43
Dentsply Sirona
XRAY
$1.75B
$1.56M 0.44%
26,887
+1,172
+5% +$72.2K
2021 Q1
2 quarters
FISV icon
44
Fiserv Inc
FISV
$25.1B
$1.52M 0.42%
+14,007
New +$1.56M
2021 Q3
0 quarters
AUDC icon
45
AudioCodes
AUDC
$270M
$1.51M 0.42%
46,296
+4,506
+11% +$146K
2021 Q1
2 quarters
APH icon
46
Amphenol
APH
$201B
$1.46M 0.41%
79,552
+12,932
+19% +$237K
2021 Q1
2 quarters
CVS icon
47
CVS Health
CVS
$118B
$1.41M 0.39%
16,599
+717
+5% +$60.1K
2021 Q1
2 quarters
RARE icon
48
Ultragenyx Pharmaceutical
RARE
$1.49B
$1.35M 0.38%
+14,990
New +$1.35M
2021 Q3
0 quarters
TEL icon
49
TE Connectivity
TEL
$60.7B
$1.33M 0.37%
9,673
+547
+6% +$79K
2021 Q1
2 quarters
STX icon
50
Seagate
STX
$154B
$1.27M 0.36%
15,454
+654
+4% +$56.9K
2021 Q2
1 quarter
1
2
3 4 5

Similar funds

PCA
Providence Capital Advisors Charlotte, North Carolina $660M AUM 17.81% 1-Year Est. Return
EIP
Ellis Investment Partners Berwyn, Pennsylvania $660M AUM 26.32% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $660M AUM 27% 1-Year Est. Return
PIFP
Partners in Financial Planning Salem, Virginia $660M AUM 15.1% 1-Year Est. Return
BMWS
Brady Martz Wealth Solutions Grand Forks, North Dakota $662M AUM 22.48% 1-Year Est. Return
WFA
West Financial Advisors Des Moines, Iowa $659M AUM 17.93% 1-Year Est. Return
PL
Pandi LLC Leawood, Kansas $658M AUM 19.94% 1-Year Est. Return
WCP
Wick Capital Partners Wayne, Pennsylvania $663M AUM 22.39% 1-Year Est. Return

Beck Bode LLC's Q3 2021 Portfolio in Review

As of Q3 2021, Beck Bode LLC held 343 positions worth $359M, down 1% from $362M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Beck Bode LLC's Q3 2021 filing shows 16 new, 39 increased, 25 reduced and 256 closed positions. Its largest new stake was Maravai LifeSciences: 160,064 shares worth $7.86M. The largest sale was Accendra Health, an estimated $13.3M.

By sector, the portfolio is most concentrated in Utilities at 31% of assets, down from 33% a quarter earlier, followed by Technology and Healthcare.

  • Beck Bode LLC's largest Q3 2021 buy was Maravai LifeSciences: 160,064 shares worth $7.86M.
  • Beck Bode LLC added most to OGE Energy in Q3 2021, an estimated $11.9M increase.
  • Beck Bode LLC's biggest Q3 2021 reduction was ExxonMobil, cutting an estimated $6.16M.
  • Beck Bode LLC fully exited Accendra Health in Q3 2021, selling an estimated $13.3M.
  • Beck Bode LLC's ten largest holdings make up 37% of its $359M portfolio in Q3 2021.
  • Beck Bode LLC opened 16 new positions and closed 256 in Q3 2021.
  • Beck Bode LLC's portfolio value fell 1% quarter-over-quarter to $359M.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.